{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:20:00Z","timestamp":1787872800348,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270830"],"award-info":[{"award-number":["82270830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2022CFB072"],"award-info":[{"award-number":["2022CFB072"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubei Province Key Laboratory of Molecular Imaging","award":["2024FZYX022"],"award-info":[{"award-number":["2024FZYX022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-026-03634-7","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:51:53Z","timestamp":1781783513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk stratification for reoperation outcomes in recurrent or persistent papillary thyroid carcinoma: development and validation of a machine learning model"],"prefix":"10.1186","volume":"26","author":[{"given":"Zimei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-8621","authenticated-orcid":false,"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"3634_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10:264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3634_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/hed.23615","volume":"37","author":"ML Urken","year":"2015","unstructured":"Urken ML, Milas M, Randolph GW, Tufano R, Bergman D, Bernet V, et al. Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: A multifactorial decision-making guide for the thyroid cancer care collaborative: Recurrent and Persistent Metastatic Lymph Nodes in Well-Differentiated Thyroid Cancer. Head Neck. 2015;37:605\u201314.","journal-title":"Head Neck"},{"key":"3634_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamaoto.2016.1114","volume":"142","author":"GL Clayman","year":"2016","unstructured":"Clayman GL, Steward DL. Management of Persistent or Recurrent Structural Neck Disease in Differentiated Thyroid Carcinoma: Point and Counterpoint. JAMA Otolaryngol Head Neck Surg. 2016;142:789.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"3634_CR4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/cancers15030923","volume":"15","author":"BG Cavalheiro","year":"2023","unstructured":"Cavalheiro BG, Shah JP, Randolph GW, Medina JE, Tufano RP, Zafereo M, et al. Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review. Cancers (Basel). 2023;15:923.","journal-title":"Cancers (Basel)"},{"key":"3634_CR5","first-page":"1020","volume":"102","author":"L Lamartina","year":"2017","unstructured":"Lamartina L, Borget I, Mirghani H, Al Ghuzlan A, Berdelou A, Bidault F, et al. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors. J Clin Endocrinol Metab. 2017;102:1020\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"3634_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1245\/s10434-019-07263-5","volume":"26","author":"AE Onuma","year":"2019","unstructured":"Onuma AE, Beal EW, Nabhan F, Hughes T, Farrar WB, Phay J, et al. Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up. Ann Surg Oncol. 2019;26:1737\u201343.","journal-title":"Ann Surg Oncol"},{"key":"3634_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.surg.2020.09.033","volume":"169","author":"S Xu","year":"2021","unstructured":"Xu S, Li Q, Wang Z, Huang H, Wang X, Liu S, et al. Evaluating the risk of re-recurrence in patients with persistent\/recurrent thyroid carcinoma after initial reoperation. Surgery. 2021;169:837\u201343.","journal-title":"Surgery"},{"key":"3634_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1\u2013133.","journal-title":"Thyroid"},{"key":"3634_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamasurg.2018.2659","volume":"153","author":"ML Hung","year":"2018","unstructured":"Hung ML, Wu JX, Li N, Livhits MJ, Yeh MW. Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer. JAMA Surg. 2018;153:1098.","journal-title":"JAMA Surg"},{"key":"3634_CR10","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00268-015-3052-2","volume":"39","author":"HS Lee","year":"2015","unstructured":"Lee HS, Roh J-L, Gong G, Cho K-J, Choi S-H, Nam SY, et al. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent\/Persistent Papillary Thyroid Carcinoma. World J Surg. 2015;39:1943\u201350.","journal-title":"World J Surg"},{"key":"3634_CR11","unstructured":"Xianyang Luo AC. Analysis of risk factors for postoperative recurrence of thyroid cancer. 2019."},{"key":"3634_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1089\/thy.2015.0433","volume":"26","author":"JW Kim","year":"2016","unstructured":"Kim JW, Roh J-L, Gong G, Cho K-J, Choi S-H, Nam SY, et al. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma. Thyroid. 2016;26:262\u201370.","journal-title":"Thyroid"},{"key":"3634_CR13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/JS9.0000000000000814","volume":"110","author":"Y Li","year":"2023","unstructured":"Li Y, Wu F, Ge W, Zhang Y, Hu Y, Zhao L, et al. Risk stratification of papillary thyroid cancers using multidimensional machine learning. Int J Surg. 2023;110:372\u201384.","journal-title":"Int J Surg"},{"key":"3634_CR14","unstructured":"Lamartina L. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors. J Clin Endocr Metab. 2017. https:\/\/doi.org\/20170130230000"},{"key":"3634_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27:315\u201389.","journal-title":"Thyroid"},{"key":"3634_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1089\/thy.2011.0170","volume":"21","author":"GL Clayman","year":"2011","unstructured":"Clayman GL, Agarwal G, Edeiken BS, Waguespack SG, Roberts DB, Sherman SI. Long-term outcome of comprehensive central compartment dissection in patients with recurrent\/persistent papillary thyroid carcinoma. Thyroid. 2011;21:1309\u201316.","journal-title":"Thyroid"},{"key":"3634_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/thy.2017.0203","volume":"27","author":"SB Chinn","year":"2017","unstructured":"Chinn SB, Zafereo ME, Waguespack SG, Edeiken BS, Roberts DB, Clayman GL. Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer. Thyroid. 2017;27:1291\u20139.","journal-title":"Thyroid"},{"key":"3634_CR18","doi-asserted-by":"publisher","first-page":"991876","DOI":"10.3389\/fendo.2022.991876","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Guo N, Gao X, Liang J, Fan X, Zhao Y. Meta-analysis of TSH suppression therapy and the risk of cardiovascular events after thyroid cancer surgery. Front Endocrinol (Lausanne). 2022;13:991876.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3634_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1210\/jc.2014-4332","volume":"100","author":"E Ruel","year":"2015","unstructured":"Ruel E, Thomas S, Dinan M, Perkins JM, Roman SA, Sosa JA. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab. 2015;100:1529\u201336.","journal-title":"J Clin Endocrinol Metab"},{"key":"3634_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12893-022-01819-1","volume":"22","author":"W Sun","year":"2022","unstructured":"Sun W, Di L, Chen L, Li D, Wu Y, Xiang J, et al. The outcomes and prognostic factors of patients who underwent reoperation for persistent\/recurrent papillary thyroid carcinoma. BMC Surg. 2022;22:374.","journal-title":"BMC Surg"},{"key":"3634_CR21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s11604-023-01438-7","volume":"41","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhu X, Fan Q, Huang Q, Tu Y, Jiang L, et al. Utility of adjuvant radioactive iodine therapy after reoperation in papillary thyroid carcinoma with cervical lymph node recurrence. Jpn J Radiol. 2023;41:1148\u201356.","journal-title":"Jpn J Radiol"},{"key":"3634_CR22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0388","author":"C Hedman","year":"2018","unstructured":"Hedman C, Djarv T, Strang P, Lundgren CI. Fear of Recurrence and View of Life Affect Health-Related Quality of Life in Patients with Differentiated Thyroid Carcinoma: A Prospective Swedish Population-Based Study. Thyroid. 2018. https:\/\/doi.org\/10.1089\/thy.2018.0388.","journal-title":"Thyroid"},{"key":"3634_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s13304-019-00647-y","volume":"71","author":"F Medas","year":"2019","unstructured":"Medas F, Tuveri M, Canu GL, Erdas E, Calo PG. Complications after reoperative thyroid surgery: retrospective evaluation of 152 consecutive cases. Updates Surg. 2019;71:705\u201310.","journal-title":"Updates Surg"},{"key":"3634_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022;23:40\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3634_CR25","doi-asserted-by":"publisher","first-page":"109203","DOI":"10.1016\/j.envint.2024.109203","volume":"195","author":"F Wang","year":"2025","unstructured":"Wang F, Lin Y, Qin L, Zeng X, Jiang H, Liang Y, et al. Serum metabolome associated with novel and legacy per- and polyfluoroalkyl substances exposure and thyroid cancer risk: A multi-module integrated analysis based on machine learning. Environ Int. 2025;195:109203.","journal-title":"Environ Int"},{"key":"3634_CR26","doi-asserted-by":"publisher","first-page":"bbae344","DOI":"10.1093\/bib\/bbae344","volume":"25","author":"O Tutsoy","year":"2024","unstructured":"Tutsoy O, Sumbul HE. A novel deep machine learning algorithm with dimensionality and size reduction approaches for feature elimination: thyroid cancer diagnoses with randomly missing data. Brief Bioinform. 2024;25:bbae344.","journal-title":"Brief Bioinform"},{"key":"3634_CR27","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/hed.24513","volume":"38","author":"J Scharpf","year":"2016","unstructured":"Scharpf J, Tuttle M, Wong R, Ridge D, Smith R, Hartl D, et al. Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement. Head Neck. 2016;38:1862\u20139.","journal-title":"Head Neck"},{"key":"3634_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.surg.2017.05.028","volume":"163","author":"MF Bates","year":"2018","unstructured":"Bates MF, Lamas MR, Randle RW, Long KL, Pitt SC, Schneider DF, et al. Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease? Surgery. 2018;163:118\u201323.","journal-title":"Surgery"},{"key":"3634_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/JS9.0000000000000316","volume":"109","author":"S-T Yu","year":"2023","unstructured":"Yu S-T, Ge J, Wei Z, Sun B, Xiao Z, Li T, et al. The lymph node yield in the initial lateral neck dissection predicts recurrence in the lateral neck of papillary thyroid carcinoma: a revision surgery cohort study. Int J Surg. 2023;109:1264\u201370.","journal-title":"Int J Surg"},{"key":"3634_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/0008-5472.CAN-13-2228","volume":"74","author":"CM Kitahara","year":"2014","unstructured":"Kitahara CM, Gamborg M, Berrington de Gonz\u00e1lez A, S\u00f8rensen TIA, Baker JL. Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res. 2014;74:235\u201342.","journal-title":"Cancer Res"},{"key":"3634_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S2213-8587(24)00310-3","volume":"13","author":"MM Chen","year":"2025","unstructured":"Chen MM, Luu M, Sacks WL, Orloff L, Wallner LP, Clair JM-S, et al. Trends in incidence, metastasis, and mortality from thyroid cancer in the USA from 1975 to 2019: a population-based study of age, period, and cohort effects. Lancet Diabetes Endocrinol. 2025;13:188\u201395.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3634_CR32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s10552-011-9747-2","volume":"22","author":"M Almquist","year":"2011","unstructured":"Almquist M, Johansen D, Bj\u00f6rge T, Ulmer H, Lindkvist B, Stocks T, et al. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control. 2011;22:743\u201351.","journal-title":"Cancer Causes Control"},{"key":"3634_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12020-017-1401-7","volume":"58","author":"C-T Shen","year":"2017","unstructured":"Shen C-T, Zhang X-Y, Qiu Z-L, Sun Z-K, Wei W-J, Song H-J, et al. Thyroid autoimmune antibodies in patients with papillary thyroid carcinoma: a double-edged sword? Endocrine. 2017;58:176\u201383.","journal-title":"Endocrine"},{"key":"3634_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12937-025-01097-6","volume":"24","author":"H Chen","year":"2025","unstructured":"Chen H, Yang Q, Zheng H, Tan J, Xie J, Xu M, et al. Planetary health diet index and mortality among US cancer survivors: mediating roles of systemic immune-inflammation index and neutrophil-to-lymphocyte ratio. Nutr J. 2025;24:28.","journal-title":"Nutr J"},{"key":"3634_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-024-00722-6","volume":"13","author":"T He","year":"2025","unstructured":"He T, Xu B, Wang L-N, Wang Z-Y, Shi H-C, Zhong C-J, et al. The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy. Biomark Res. 2025;13:10.","journal-title":"Biomark Res"},{"key":"3634_CR36","doi-asserted-by":"publisher","first-page":"1253394","DOI":"10.3389\/fendo.2023.1253394","volume":"14","author":"J Cao","year":"2023","unstructured":"Cao J, He X, Li X, Sun Y, Zhang W, Li Y, et al. The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes. Front Endocrinol (Lausanne). 2023;14:1253394.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3634_CR37","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.eclinm.2024.102913","volume":"77","author":"F Hou","year":"2024","unstructured":"Hou F, Zhu Y, Zhao H, Cai H, Wang Y, Peng X, et al. Development and validation of an interpretable machine learning model for predicting the risk of distant metastasis in papillary thyroid cancer: a multicenter study. EClinicalMedicine. 2024;77:102913.","journal-title":"EClinicalMedicine"},{"key":"3634_CR38","doi-asserted-by":"publisher","first-page":"137382","DOI":"10.1016\/j.jhazmat.2025.137382","volume":"488","author":"Y Takefuji","year":"2025","unstructured":"Takefuji Y. Beyond XGBoost and SHAP: Unveiling true feature importance. J Hazard Mater. 2025;488:137382.","journal-title":"J Hazard Mater"},{"key":"3634_CR39","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","volume":"32","author":"M Xing","year":"2014","unstructured":"Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014;32:2718\u201326.","journal-title":"J Clin Oncol"},{"key":"3634_CR40","doi-asserted-by":"publisher","first-page":"eadg7125","DOI":"10.1126\/sciadv.adg7125","volume":"9","author":"P Yu","year":"2023","unstructured":"Yu P, Qu N, Zhu R, Hu J, Han P, Wu J, et al. TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis. Sci Adv. 2023;9:eadg7125.","journal-title":"Sci Adv"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-026-03634-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:05:15Z","timestamp":1787871915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-026-03634-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3634"],"URL":"https:\/\/doi.org\/10.1186\/s12911-026-03634-7","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology ([2020]0340-01). The entire study was conducted in accordance with the Helsinki Declaration, and informed consent was obtained from each participant prior to the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"327"}}